Akshay Vaishnaw Insider Trading
Get free email notifications about insider trading for Akshay Vaishnaw.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Akshay Vaishnaw. Akshay Vaishnaw is a EVP, Chief Medical Officer in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a EVP, R&D in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a EVP, R&D, CMO in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a President, R&D in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a SVP, R&D in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a Director in Editas Medicine, Inc. ($EDIT) and a Director in Scholar Rock Holding Corp ($SRRK).
Address: 300 THIRD STREET CAMBRIDGE 02142 MA
Companies in which Akshay Vaishnaw is an Insider
ALNYLAM PHARMACEUTICALS, INC.
Trading Symbol: ALNYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Akshay Vaishnaw: President, R&D, SVP, R&D, EVP, R&D, CMO, EVP, Chief Medical Officer
Holdings: 22,908 shares
Current Value: $926,858
Latest Transaction: Apr 21 2021
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Editas Medicine, Inc.
Trading Symbol: EDITIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Akshay Vaishnaw: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 14 2019
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Scholar Rock Holding Corp
Trading Symbol: SRRKIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Akshay Vaishnaw: Director
Holdings: 0 shares
Latest Transaction: Jun 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Akshay Vaishnaw
Sentiment: All, ALNY, EDIT, SRRK
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 138.48 | 107 | 14,817 | 14,119 | 14.2 K to 14.1 K (-0.75 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 137.60 | 530 | 72,928 | 14,226 | 14.8 K to 14.2 K (-3.59 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 136.84 | 1,892 | 258,901 | 14,756 | 16.6 K to 14.8 K (-11.36 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 135.41 | 203 | 27,488 | 16,648 | 16.9 K to 16.6 K (-1.20 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 134.56 | 85 | 11,438 | 16,851 | 16.9 K to 16.9 K (-0.50 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 131.75 | 2,266 | 298,546 | 16,936 | 19.2 K to 16.9 K (-11.80 %) |
Apr 21 2021 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 140.02 | 417 | 58,388 | 19,202 | 19.6 K to 19.2 K (-2.13 %) |